Full Press Release Details
Results of Annual General Meeting
The results of Prima BioMed Limited (ASX:PRR) Annual General Meeting held earlier today are set out in the attached document.
All resolutions were passed on a show of hands.
information please contact:
Campbell, Vice President of Business Development and Investor Relations, Immutep
Matthew Beck, The Trout Group LLC
+1 (646) 378-2933; mbeck@troutgroup.com
Australian Investors/Media:
Matthew Gregorowski,
+61 2 8234 0105; mgregorowski@citadelmagnus.com
The following information is provided in accordance with section 251AA(2) of the Corporations Act 2001 (Cth).
| Resolution details | Instructions given to validly appointed proxies (as at proxy close) | Number of votes cast on the poll (where applicable) | Resolution Result | |||||||||||||||||||||||
| Resolution | Resolution Type | For | Against | Proxy s Discretion | Abstain | For | Against | Abstain* | Carried / Not Carried | |||||||||||||||||
| 1. Non-binding resolution to adopt Remuneration | Ordinary | 329,042,324 | 11,958,840 | 13,914,225 | 8,666,212 | N/A | Carried | |||||||||||||||||||
| 92.71% | 3.37% | 3.92% | ||||||||||||||||||||||||
| 2. Re-election of Director - Mr Pete Meyers | Ordinary | 423,434,247 | 5,424,219 | 18,732,302 | 1,872,380 | N/A | Carried | |||||||||||||||||||
| 94.60% | 1.21% | 4.19% | ||||||||||||||||||||||||
| 3. Re-election of Director - Mr Grant Chamberlain | Ordinary | 423,255,396 | 5,435,199 | 18,716,173 | 2,056,380 | N/A | Carried | |||||||||||||||||||
| 94.60% | 1.21% | 4.18% | ||||||||||||||||||||||||
| 4. Approval of additional 10% placement capacity | Special | 373,813,572 | 52,830,576 | 20,135,945 | 2,683,055 | N/A | Carried | |||||||||||||||||||
| 83.67% | 11.82% | 4.51% | ||||||||||||||||||||||||
| 5. Approval of grant of performance rights to Mr Grant Chamberlain | Ordinary | 298,444,769 | 47,716,662 | 9,909,192 | 7,510,978 | N/A | Carried | |||||||||||||||||||
| 83.82% | 13.40% | 2.78% | ||||||||||||||||||||||||
| 6. Approval of grant of performance rights to Mr Marc Voigt | Ordinary | 298,272,289 | 50,115,860 | 9,961,692 | 5,231,760 | N/A | Carried | |||||||||||||||||||
| 83.23% | 13.99% | 2.78% | ||||||||||||||||||||||||
| 7. Change of Company name | Special | 406,259,325 | 16,977,195 | 19,406,793 | 6,819,835 | N/A | Carried | |||||||||||||||||||
| 91.78% | 3.84% | 4.38% | ||||||||||||||||||||||||
| 8. Ratification of previous Share and Warrant issue | Ordinary | 296,649,794 | 8,207,974 | 20,939,694 | 5,215,835 | N/A | Carried | |||||||||||||||||||
| 91.05% | 2.52% | 6.43% | ||||||||||||||||||||||||
| 9. Approval of termination benefits for eligible executives | Ordinary | 280,002,446 | 54,972,807 | 13,492,986 | 15,113,362 | N/A | Carried | |||||||||||||||||||
| 80.35% | 15.78% | 3.87% |